Are weight loss injections a healthy choice? The factors that matter

The real decision: is the health risk of staying at your current weight greater than the risk of treatment?

This is the question a prescriber is actually weighing when they assess you. Obesity is itself a significant health condition. It is associated with type 2 diabetes, hypertension, obstructive sleep apnoea, certain cancers, cardiovascular disease and joint problems, among others. The NHS describes obesity as a complex condition shaped by biology, not a failure of willpower.

GLP-1 and dual GIP/GLP-1 medicines work by mimicking gut hormones that regulate appetite and slow gastric emptying, reducing how much you feel like eating. The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported average body-weight reductions of around 20–21% over 72 weeks at the 15mg dose of tirzepatide. Reductions of that scale are associated with clinically meaningful falls in blood pressure, fasting glucose and LDL cholesterol. For the majority of people who qualify, the evidence consistently points toward net benefit, but that calculation is personal and medical, not one-size-fits-all.

If you want to explore how the health picture shifts with treatment, the documented health benefits of weight loss injections are worth reading before a consultation.

Side effects: what healthy use actually involves

No medicine is without risk, and these are no exception. The most commonly reported effects are gastrointestinal: nausea, loose stools, constipation, indigestion, and bloating. They are most noticeable in the first few weeks after starting or after a dose increase, and for most people they settle. Some people also notice changes in their energy levels, and if that is something you are thinking about, our page on whether weight loss injections give you energy looks at what the evidence actually shows.

More serious but less common effects include acute pancreatitis. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting this risk for GLP-1 medicines: seek urgent medical help for severe, persistent stomach pain that radiates toward the back, particularly if accompanied by vomiting. You can report any suspected side effects through the MHRA's Yellow Card scheme.

There are also practical habits that reduce risk. Staying well hydrated matters more than usual when nausea is present. Protein intake deserves attention because appetite suppression can lead to under-eating, which affects muscle as well as fat. Our page on health concerns around weight loss injections covers these in more detail.

One small but real routine detail: keeping your pen in the fridge door, where you see it weekly, makes it far less likely you forget to rotate injection sites or miss a dose during a busy week. Small habits support safe use as much as any clinical guidance does.

Who should and should not consider them

Both Mounjaro and Wegovy are licensed for adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, high cholesterol, prediabetes or obstructive sleep apnoea. NICE recommends tirzepatide for NHS use in adults with a BMI of 35 or above plus at least one qualifying comorbidity, under NICE technology appraisal TA1026. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance.

They are not recommended during pregnancy, breastfeeding, or for anyone who is trying to conceive. They are not licensed for under-18s. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, or a history of pancreatitis, require careful prescriber discussion before starting.

Women taking oral contraceptives who start tirzepatide should use a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill may be reduced. NHS England's guidance on weight management injections covers this and other practical considerations in detail.

BMI alone does not determine suitability. A prescriber weighs your full picture, including any medicines you take and conditions you have.

Where the source of treatment fits into the health question

This point is rarely raised but matters considerably. These are prescription-only medicines. Obtaining them without a valid prescription (from unverified online sellers, social media advertisements, or sellers advertising prices far below the market) carries serious risk. The MHRA has warned publicly about counterfeit weight loss pens that have been found to contain insulin rather than the stated active ingredient, with some users hospitalised as a result.

A legitimate supply means a prescription written by a qualified, accountable clinician who has actually assessed you. That clinical layer is part of what makes use safer. If you are comparing options and want to understand which treatments have the strongest safety profile, our page on the healthiest weight loss injections sets out what the evidence says about each. If cost is also a factor, our page on cheap weight loss injections addresses what low prices sometimes mean in practice, it is worth reading before making any decision.

At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber, and the same clinical review happens before every repeat order. You can read more about how we work or explore our weight loss injection overview if you want a broader picture of both treatments before deciding whether to start a conversation with our clinical team.